Abstract
We conducted a prospective randomized trial to compare the efficacy and survival outcome by chemoradiation with that by esophagectomy as a curative treatment. From July 2000 to December 2004, 80 patients with potentially resectable squamous cell carcinoma of the mid or lower thoracic esophagus were randomized to esophagectomy or chemoradiotherapy. A two-or three-stage esophagectomy with two-field dissection was performed. Patients treated with chemoradiotherapy received continuous 5-.uorouracil infusion (200 mg/m2/day) from day 1 to 42 and cisplatin (60 mg/m2) on days 1 and 22. The tumor and regional lymphatics were concomitantly irradiated to a total of 50–60 Gy.Tumor response was assessed by endoscopy, endoscopic ultrasonography, and computed tomography scan. Salvage esophagectomy was performed for incomplete response or recurrence. Forty-four patients received standard esophagectomy, whereas 36 were treated with chemoradiotherapy. Median follow-up was 16.9 months. The operative mortality was 6.8%. The incidence of postoperative complications was 38.6%. No difference in the early cumulative survival was found between the two groups (RR = 0.89; 95% confidence interval, 0.37-2.17; log-rank test P =0.45). There was no difference in the disease-free survival. Patients treated with surgery had a slightly higher proportion of recurrence in the mediastinum, whereas those treated with chemoradiation sustained a higher proportion of recurrence in the cervical or abdominal regions. Standard esophagectomy or chemoradiotherapy offered similar early clinical outcome and survival for patients with squamous cell carcinoma of the esophagus. The challenge lies in the detection of residue disease after chemoradiotherapy.
Similar content being viewed by others
References
Earlam R, Cunha-Melo JR. Esophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980;67:381–390.
Muller JM, Erasmi H, Stelzner M, et al. Surgical therapy of esophageal carcinoma. Br J Surg 1990;77:845–857.
Gurtner GC, Robertson CS, Chung SC, Li AK. Two-team synchronous esophagectomy. Br J Surg 1994;81:1620–1622.
Whooley BP, Law S, Murthy SC, et al. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001;233:338–344.
Stilidi I, Davydov M, Bokhyan V, et al. Subtotal esophagectomy with extended 2-.eld lymph node dissection for thoracic esophageal cancer. Eur J Cardiothorac Surg 2003;23:415–420.
Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg 1999;230:392–400.
Arnott SJ, Duncan W, Kerr GR, et al. Low dose preoperative radiotherapy for carcinoma of the esophagus: Results of a randomized clinical trial. Radiother Oncol 1992;24:108–113.
Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104–1109.
Ando N, Iizuka T, Kakegawa T, et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 1997; 114:205–209.
Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979–1984.
Law S, Fok M, Chow S, et al. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial. J Thorac Cardiovasc Surg 1997;114:210–217.
Chan AC, Lee DW, Griffin JF, et al. The clinical efficacy of neoadjuvant chemotherapy in squamous esophageal cancer: A prospective nonrandomized study of pulse and continuousinfusion regimens with cisplatin and 5-.uorouracil. Ann Surg Oncol 2002;9:617–624.
Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462–467.
Bosset J, Gignoux M, Triboulet J, et al. Chemotherapy followed by surgery compared with surgery alone in squamous cell cancer of esophagus. N Engl J Med 1997;337:161–167.
Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19:305–313.
El Nakadi I, Van Laethem JL, Houben JJ, et al. Squamous cell carcinoma of the esophagus: Multimodal therapy in locally advanced disease. World J Surg 2002;26:72–78.
Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiotherapy for esophageal cancer: A systematic review and meta-analysis. Gut 2004;53:925–930.
Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy and surgery versus surgery for localized squamous cell carcinoma of esophagus. Cancer 1994;73:1779–1784.
Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41:391–393.
Kitamura K, Kuwano H, Watanabe M, et al. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 1995;60:55–58.
Forastiere AA, Orringer MB, Perez-Tramayo C, et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993;11:1118–1123.
Le Prise EA, Meunier BC, Etienne PL, et al. Sequential chemotherapy and radiotherapy for patients with squamous cell carcinoma of the esophagus. Cancer 1995;75:430–434.
Cooper SJ, Guo MD, Herskovic A, et al. Chemoradiotherapy for locally advanced esophageal cancer—lLong term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999;281:1623–1627.
Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) comparedwith radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database System Rev 2004;2.
Hulsher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662–1669.
Nakamura T, Hayashi K, Masaho Ota, et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004;188:261–266.
Blazeby JM, Farndon JR, Donovan J, et al. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000;88:1781–1787.
Law S, Wong J. Two field dissection is enough for esophageal cancer. Dis Esophagus 2001;14:98–103.
Law S, Wong J. Current management of esophageal cancer. J Gastrointest Surg 2005;9:291–310.
Isono K, Sato H, Nakayama K. Results of a nationwide study on the three fields of lymph node dissection in esophageal cancer. Oncology 1991;51:931–935.
Lerut T, Nafteux P, Moons J, et al. Three-.eld lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: Impact on staging, diseasefree survival, and outcome: A plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004;240:962–972.
Griffith JF, Chan AC, Chow LT, et al. Assessing chemotherapy response of squamous cell esophageal carcinoma with spiral CT. Br J Radiol 1999;72:678–684.
Jones DR, Parker LA, Detterbeck FC, et al. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer 1999; 85:1026–1032.
Giovannini M, Seitz JF, Thomas P, et al. Endoscopic ultrasonography for assessment of the response to combined radiation therapy and chemotherapy in patients with esophageal cancer. Endoscopy 1997;29:4–9.
Beseth BD, Bedford R, Isacoff WH, et al. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000;66:827–831.
Swisher SG, Maish M, Erasmus JJ, et al. Utility of PET, CT and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 2004;78:1152–1160.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the Research Grant Council (RGC) of Hong Kong Special Administrative Region, China.
Rights and permissions
About this article
Cite this article
Chiu, P.W.Y., Chan, A.C.W., Leung, S.F. et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: Early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 9, 794–802 (2005). https://doi.org/10.1016/j.gassur.2005.05.005
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2005.05.005